Mindray Medical International Announces Third Quarter 20...(24.7% 27.8% 27.8% Non-G...)

Non-GAAP income per share - basic 3.41 4.58 0.61

Non-GAAP income per share - diluted 3.02 4.32 0.58

GAAP income per share - basic 3.17 4.08 0.55

GAAP income per share - diluted 2.80 3.85 0.51

Shares used in computation of:

Basic earnings per share 80,777,302 106,171,253 106,171,253

Diluted earnings per share 91,314,023 112,620,932 112,620,932

Non-GAAP operating income 294,353 497,690 66,422

Non-GAAP operating margin 28.4% 32.0% 32.0%

Expense/Amortization of acquired

intangible assets -- (14,122) (1,885)

Share-based compensation (19,513) (40,946) (5,465)

GAAP operating income 274,840 442,622 59,073

GAAP operating margin 26.5% 28.4% 28.4%

Non-GAAP gross profit 570,962 882,960 117,841

Non-GAAP gross margin 55.0% 56.7% 56.7%

Expense/Amortization of acquired

intangible assets -- (14,122) (1,885)

Share-based compensation (426) (1,187) (158)

GAAP gross profit 570,536 867,651 115,798

GAAP gross margin 55.0% 55.7% 55.7%

For investor and media inquiries, please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: IR@Mindray.com

Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556

Email: